These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18535871)
1. The potential use of ephedrine in Lambert-Eaton myasthenic syndrome : clinical and electrophysiological evaluation. Cereda C; Kuntzer T J Neurol; 2008 Aug; 255(8):1259-60. PubMed ID: 18535871 [No Abstract] [Full Text] [Related]
2. Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy. Cooke JD; Hefter H; Brown SH; Toyka KV; Freund HJ Electromyogr Clin Neurophysiol; 1994 Mar; 34(2):87-93. PubMed ID: 8187683 [No Abstract] [Full Text] [Related]
3. Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome. Maddison P; Newsom-Davis J; Mills KR Muscle Nerve; 1998 Sep; 21(9):1196-8. PubMed ID: 9703446 [TBL] [Abstract][Full Text] [Related]
15. Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article. Lorenzoni PJ; Kay CSK; Werneck LC; Scola RH Arq Neuropsiquiatr; 2018 Feb; 76(2):124-126. PubMed ID: 29489969 [TBL] [Abstract][Full Text] [Related]
16. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. McEvoy KM; Windebank AJ; Daube JR; Low PA N Engl J Med; 1989 Dec; 321(23):1567-71. PubMed ID: 2555713 [TBL] [Abstract][Full Text] [Related]
17. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome. Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949 [TBL] [Abstract][Full Text] [Related]
18. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports. Schneider I; Kornhuber ME; Hanisch F J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033 [TBL] [Abstract][Full Text] [Related]